Search

everythinglearnresearchcommunity

for

Search:↓

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Low-Level Laser Therapy may help reduce chronic pelvic pain in women.

FDA-cleared devices often fail to produce high-quality platelet-rich plasma consistently.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

5-Alpha-Reductase Inhibitors can cause negative side effects.

New therapies are being developed that target integrin pathways to treat various diseases.

The research explains how a human enzyme binds and processes its substrate, which could relate to its role in biological functions and hair loss.

GLABRA2 represses root hair formation by inhibiting a specific gene.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

Platelet-rich treatments can help improve wound healing and tissue repair.

PLGA-based microneedles show promise for painless, long-term drug delivery but need design and safety improvements.

Platelet-rich plasma (PRP) treatments are not effective.

The document sets guidelines to standardize reporting of PRP clinical trials for better reproducibility and comparability.

The new drug delivery systems made with surfactants and block polymers are stable and not toxic.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Early recognition and a team approach are crucial for managing diffuse alveolar hemorrhage in antiphospholipid syndrome.

PRP treatment improved skin pigmentation and appearance in facial lichen planus pigmentosus.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

Mixing platelet-rich plasma with Poly-D,L-Lactic Acid helps reduce deep lines around the nose and mouth.

PRP shows promise but lacks consistent evidence and regulation.

Valproic acid can cause low platelet counts, especially at high doses or in elderly patients.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.